Comprehensive Cancer Centers of Nevada
Mesfin Kidane is currently serving as the Diagnostic/ Nuclear Medicine Manager at Comprehensive Cancer Centers of Nevada since November 2019. Prior to this role, Mesfin has been with US Oncology since August 2009, starting as a Nuclear Medicine/PET CT Technologist and later also taking on the role of a Diagnostic CT Technologist. Mesfin holds a Master's degree in Health/Health Care Administration/Management from the University of Phoenix, achieved between 2014-2017. Additionally, Mesfin also holds a Bachelor of Science degree in Nuclear Medical Technology/Technologist from the University of Nevada-Las Vegas, completed between 2007-2010.
Comprehensive Cancer Centers of Nevada
Comprehensive Cancer Centers of Nevada is the award-winning multi-specialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research with treatment centers and offices throughout Southern Nevada. Comprehensive has provided oncology services to Southern Nevada residents and visitors for more than 40 years. The practice’s specialized physician and nursing staff offers sophisticated diagnostic tools, the latest advances in cancer treatment, a full range of innovative, exclusive services and research-based care in a supportive and caring environment. In order to provide patients the most progressive and effective cancer treatments, Comprehensive expanded its clinical research program by partnering with some of the world’s most recognizable research and cancer-fighting organizations. In 1995, Comprehensive physicians became part of The US Oncology Network, one of the nation’s largest networks of community-based oncology physicians dedicated to advancing cancer care in America. Today, Comprehensive participates in more than 170 Phase I, Phase II and Phase III clinical research studies each year, and has helped develop more than 100 FDA approved cancer therapies including approvals for Hercepin, Provenge, TECENTRIQ®, Xofigo, Keytruda and others.